Primer: Akebia Therapeutics (AKBA US) - Aug 2026
Akebia Therapeutics is a biopharmaceutical company focused on kidney disease, with its lead product, Vafseo® (vadadustat), recently approved in...
97 Views
Pakistan Banks: Central Bank Amends MDR Rules; MDR Removed on Trusts, Pvt Limited, and Individuals
The State Bank of Pakistan (SBP) has removed the Minimum Deposit Rate (MDR) requirement on Trusts, Private limited businesses and for Individual...
140 Views
Pakistan Fertilizer: Fertilizers Profits Likely to Rise 20% YoY in 3Q2026; Led by Higher Realized Prices
We expect Topline Fertilizer universe earnings to rise by 20% YoY and 7% QoQ in 3Q2026, primarily driven by higher urea sales volumes,...
86 Views
Akebia Therapeutics Inc (AKBA) - Friday, Oct 25, 2024
Despite their challenges, the company's stock is seen as undervalued and has the potential to reach a price target of $5.00+.
607 Views
Otsuka Holdings (4578 JP) 1Q22: Global Products Continued Double-Digit Revenue Growth
Otsuka reported 13% y/y revenue growth in Q1, driven by four global products and reiterated 2022 guidance. Despite recent pipeline blues, Otsuka’s...
544 Views